📈Growing biotech businesses 🧬 Translating science into action 🤝 Co-host GROW EVERYTHING pod 🎙️
🔬Messaginglab and Degron Therapeutics Partnered on a $1.2B Collaboration Announcement - With Big Results 🧬 We're thrilled to have collaborated with Degron Therapeutics - an emerging leader in the discovery of small molecule, molecular glue degrader drugs - on their recent press release announcing their $1.2B collaboration with Takeda. Molecular glue degraders are small molecule drugs that act as adhesives by bringing a disease target protein to another protein called E3 ligase, which is a component of a protein degradation machinery. As a result, the disease target protein is “tagged” as trash and degraded in the cell. This approach has the potential to target previously undruggable proteins, opening new avenues for treating challenging diseases in cancer, inflammation, neurodegenerative and other disorders. Messaginglab's Impact: 💡Translating Difficult Science: We simplified the complexity of molecular glues to help Degron reach a broader audience. Our approach resonated widely for investors, partners, and the public. 💡Amplifying Media Presence: Through targeted outreach, we secured coverage in 20 top life science and pharma publications, including Biocentury, BioWorld, Chemical & Engineering News, and Fierce Biotech. This expanded visibility positioned Degron as a key player in biotech. 💡Crafting a Compelling Corporate Narrative: Beyond the $1.2B deal, we highlighted Degron's mission to revolutionize drug discovery. We created an emotional connection by focusing on the impact on patients' lives, elevating Degron's story above financial metrics. 💡Showcasing Thought Leadership: We positioned Degron's co-founder and CEO, Lily Zou, as a visionary leader. Her quotes and media accessibility added a human touch to the company's technological breakthroughs, building trust and credibility. 💡Driving Meaningful Engagement: Our success went beyond metrics. We focused on generating high-quality media coverage that sparked conversations among key stakeholders in the biotech community. The Power of Partnership: We're proud to have been a part of this groundbreaking work. Our collaboration with Degron Therapeutics showcases Messaginglab's ability to elevate complex science through strategic communication. #MediaRelations #BiopharmaNews
We Help YOU Retire with Confidence! | Executive Director, Branch Manager at Huffman Mayer Wealth Management Group of Wells Fargo Advisors
3mocongratulations! Seems like a great move